Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2009
08/20/2009WO2008129465A3 Stable pharmaceutical compositions of bupropion
08/20/2009WO2008124505A3 Soluble guanylate cyclase (sgc) modulators for treatment of lipid related disorders
08/20/2009WO2008092690A8 Aminoglycoside antibiotics targeting bacterial 16s ribosomal rna
08/20/2009WO2008077092A8 Combined effects of topiramate and ondansetron on alcohol consumption
08/20/2009WO2008069348A9 Pharmaceutical agent having long-lasting effect of treating arthritic disorders
08/20/2009WO2008023277A8 Compositions containing coenzyme q-10 and dihydrolipoic acid
08/20/2009WO2007099559A9 Method of preparation for novel composition of 2-{(2,6 dichlorophenyl) amino] benzeneacetic acid carboxymethyl ester or 2-[2-[2-(2,6-dichlorophenyl) amino] phenylacetoxyacetic acid and method of its use
08/20/2009WO2007008200A8 Wortmannin analogs and methods of using same in combination with chemotherapeutic agents
08/20/2009US20090210954 Genes
08/20/2009US20090210949 Method of ameliorating symptom caused by mood disturbance
08/20/2009US20090209937 Apparatus and Methods for Treating Epilepsy Using Convection-Enhanced Delivery
08/20/2009US20090209775 Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
08/20/2009US20090209748 comprise at least one Locked Nucleic Acid (LNA) selected from beta-D-thio/amino-LNA or alpha-L-oxy/thio/amino-LNA; useful in antisense therapy
08/20/2009US20090209747 Method to inhibit cell growth using oligonucleotides
08/20/2009US20090209734 Peptidyl prodrugs and linkers and stabilizers useful therefor
08/20/2009US20090209658 Embolic compositions
08/20/2009US20090209656 Disinfection/sanitation method where the material is treated with a solution comprising benzyl alcohol and c2-3 alcohol
08/20/2009US20090209655 Isoflavone metabolites
08/20/2009US20090209654 Prenylflavonoid Formulations
08/20/2009US20090209653 Agent for increasing testosterone level
08/20/2009US20090209652 Vitamin K for Prevention and Treatment of Skin Rash Secondary to Anti-EGFR Therapy
08/20/2009US20090209651 Use of 3-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl) propane-1-one for improved skin contouring or against cellulite
08/20/2009US20090209650 Materials and Methods for Improving the health of Shrimp
08/20/2009US20090209649 Alpha-glucosidase inhibitor, inhibitor for blood glucose level elevation and functional food containing tricaffeoylaldaric acid and method for producing tricaffeoylaldaric acid
08/20/2009US20090209648 Phenylacetic Acid Derivatives
08/20/2009US20090209647 Nutritional method
08/20/2009US20090209646 Tranexamic acid formulations
08/20/2009US20090209645 Methods for treating vasomotor symptoms using gaba analogs in a gastric retentive dosage form
08/20/2009US20090209644 Lipotoxicity relieving agent
08/20/2009US20090209643 Method for modulating stem cell growth
08/20/2009US20090209642 Hydroxy Acid Complexes for Antiaging and Skin Renovation
08/20/2009US20090209641 Pharmaceutical composition for administration by injection
08/20/2009US20090209640 Prevention of and countermeasures against viral infection
08/20/2009US20090209639 Process for modifying drug crystal formation
08/20/2009US20090209638 Treatment for depressive disorders
08/20/2009US20090209637 Use of chromen-4-one derivatives
08/20/2009US20090209636 Novel use of (-)-epigallocatechin gallate
08/20/2009US20090209635 Topical cromolyn formulations
08/20/2009US20090209634 Use of benzo-fused heterocycle sulfamide derivatives for disease modification / epileptogenesis
08/20/2009US20090209633 Treatment of Pain With Resiniferatoxin and Related Analogs
08/20/2009US20090209632 Percutaneously Absorptive Ophthalmic Preparation Comprising Olopatadine
08/20/2009US20090209631 Method for enhanced uptake of viral vectors in the myocardium
08/20/2009US20090209630 Vectors carrying coding sequences for angiogenic agents such as Del-1or VEGF formulated with poloxamers to improve bioavailability; avoids problems with toxicity inherent to existing delivery technologies; treating ischemia in a muscle, kidney or brain tissue
08/20/2009US20090209629 Nucleic Acid Functionalized Nanoparticles for Therapeutic Applications
08/20/2009US20090209628 MULTIPLE RNAi EXPRESSION CASSETTES FOR SIMULTANEOUS DELIVERY OF RNAi AGENTS RELATED TO HETEROZYGOTIC EXPRESSION PATTERNS
08/20/2009US20090209627 RNAi-MEDIATED INHIBITION OF CONNEXIN 43 FOR TREATMENT OF IOP-RELATED CONDITIONS
08/20/2009US20090209626 Duplex Oligonucleotides with Enhanced Functionality in Gene Regulation
08/20/2009US20090209623 Anti-sense nucleic acid derived from organism
08/20/2009US20090209622 Diagnosis of anxiety disorders
08/20/2009US20090209621 Compositions and methods for decreasing microrna expression for the treatment of neoplasia
08/20/2009US20090209620 Direct Reversal Of The Suppressive Function Of CD4+Regulatory T Cells Via Toll-Like Receptor 8 Signaling
08/20/2009US20090209619 Depression of herg k+ channel function in mammallan cells and applications to the control of cancer cells division
08/20/2009US20090209618 Pyruvate dehydrogenase kinases as therapeutic targets for cancer and ischemic diseases
08/20/2009US20090209617 Duloxetine salts
08/20/2009US20090209616 Preparation of romidepsin
08/20/2009US20090209615 Inhibitors of matrix metalloproteinases to treat neurological disorders
08/20/2009US20090209614 administering glutamine or glutamine chloride to a patient for increasing blood flow in in the capillary vessels; treating a condition selected from dementia, cold constitution, shoulder stiffness, skin muddiness, muscle fatigue, impaired liver function, lowered immunity
08/20/2009US20090209613 Use of allymercaptocaptopril for treating or preventing obesity and obesity related diseases
08/20/2009US20090209612 Process for the preparation of atorvastatin
08/20/2009US20090209611 Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them
08/20/2009US20090209610 Polymorphic form of 6-(4-chlorophenyl)-2,2-dimethyl-7-Phenyl-2,3-Dihydro-1h-Pyrrolizin-5-Ylacetic Acid
08/20/2009US20090209609 Thienopyrroles and pyrrolothiazoles as new therapeutic agents
08/20/2009US20090209608 Deuterium-enriched asenapine
08/20/2009US20090209607 Inhibitors of akt activity
08/20/2009US20090209606 Cancer Treatments
08/20/2009US20090209604 Topical combination therapy for treating acne
08/20/2009US20090209603 Olmesartan medoxomil with reduced levels of impurities
08/20/2009US20090209602 Chemical compounds
08/20/2009US20090209601 Use of rxr agonists for the treatment of osteoarthritis
08/20/2009US20090209600 Moisturization improvement via a heated niacinamide containing flowable cosmetic transferred onto skin
08/20/2009US20090209599 Eye drop containing roflumilast
08/20/2009US20090209597 Imidazole derivatives and their use for modulating the gaba alpha receptor complex
08/20/2009US20090209596 Oxazole Hydroxamic Acid Derivatives and Use Thereof
08/20/2009US20090209595 Method of treating of demyelinating diseases or conditions
08/20/2009US20090209594 Method of treating of demyelinating diseases or conditions
08/20/2009US20090209593 Novel antibacterial agents
08/20/2009US20090209592 Inhibitors of the gastric h+, k+-atpase with enhanced therapeutic properties
08/20/2009US20090209591 Pharmaceutical product for injection
08/20/2009US20090209590 Histone Deacetylase and Tubulin Deacetylase Inhibitors
08/20/2009US20090209588 Novel compounds, their preparation and use
08/20/2009US20090209587 Repaglinide formulations
08/20/2009US20090209586 Piperidine derivatives as human papilloma virus inhibitors
08/20/2009US20090209585 Cycloalkene derivatives, process for production of the derivatives, and use of the same
08/20/2009US20090209584 Antibacterial mutilins
08/20/2009US20090209583 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors
08/20/2009US20090209582 Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists
08/20/2009US20090209581 Nitroxides for use in treating or preventing immunological diseases
08/20/2009US20090209580 Antitumor agent for thyroid cancer
08/20/2009US20090209579 Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof
08/20/2009US20090209578 Chemical compounds
08/20/2009US20090209577 Novel Triazolopyridine Compounds
08/20/2009US20090209576 Pharmaceutical composition containing clopidogrel camphorsulfonate or polymorphic forms thereof
08/20/2009US20090209575 Method for treating neuropathic pain and associated syndromes
08/20/2009US20090209574 Fluoroquinolone derivatives for ophthalmic applications
08/20/2009US20090209573 Compounds and compositions as hedgehog pathway modulators
08/20/2009US20090209572 36-Des(3-Methoxy-4-Hydroxycyclohexyl) 36-(3-Hydroxycycloheptyl) Derivatives of Rapamycin for the Treatment of Cancer and Other Disorders
08/20/2009US20090209571 Phenanthrene derivatives as MPGES-1 inhibitors
08/20/2009US20090209570 6-Aminomorphinane Derivatives, Method for the Production and Use Thereof
08/20/2009US20090209569 Selective opioid compounds
08/20/2009US20090209568 Spiro [Benzopyran] or Spiro [Benzofuran] Derivatives Which Inhibit the Sigma Receptor
1 ... 2609 2610 2611 2612 2613 2614 2615 2616 2617 2618 2619 2620 2621 2622 2623 2624 2625 2626 2627 2628 2629 ... 7860